338 related articles for article (PubMed ID: 31152154)
21. Body weight regulation via MT1-MMP-mediated cleavage of GFRAL.
Chow CFW; Guo X; Asthana P; Zhang S; Wong SKK; Fallah S; Che S; Gurung S; Wang Z; Lee KB; Ge X; Yuan S; Xu H; Ip JPK; Jiang Z; Zhai L; Wu J; Zhang Y; Mahato AK; Saarma M; Lin CY; Kwan HY; Huang T; Lyu A; Zhou Z; Bian ZX; Wong HLX
Nat Metab; 2022 Feb; 4(2):203-212. PubMed ID: 35177851
[TBL] [Abstract][Full Text] [Related]
22. Uniting GDF15 and GFRAL: Therapeutic Opportunities in Obesity and Beyond.
Mullican SE; Rangwala SM
Trends Endocrinol Metab; 2018 Aug; 29(8):560-570. PubMed ID: 29866502
[TBL] [Abstract][Full Text] [Related]
23. The GDF15-GFRAL axis mediates chemotherapy-induced fatigue in mice.
Chelette B; Chidomere CL; Dantzer R
Brain Behav Immun; 2023 Feb; 108():45-54. PubMed ID: 36427806
[TBL] [Abstract][Full Text] [Related]
24. Insights Into Mechanisms of GDF15 and Receptor GFRAL: Therapeutic Targets.
Rochette L; Zeller M; Cottin Y; Vergely C
Trends Endocrinol Metab; 2020 Dec; 31(12):939-951. PubMed ID: 33172749
[TBL] [Abstract][Full Text] [Related]
25. GDF15 mediates the effects of metformin on body weight and energy balance.
Coll AP; Chen M; Taskar P; Rimmington D; Patel S; Tadross JA; Cimino I; Yang M; Welsh P; Virtue S; Goldspink DA; Miedzybrodzka EL; Konopka AR; Esponda RR; Huang JT; Tung YCL; Rodriguez-Cuenca S; Tomaz RA; Harding HP; Melvin A; Yeo GSH; Preiss D; Vidal-Puig A; Vallier L; Nair KS; Wareham NJ; Ron D; Gribble FM; Reimann F; Sattar N; Savage DB; Allan BB; O'Rahilly S
Nature; 2020 Feb; 578(7795):444-448. PubMed ID: 31875646
[TBL] [Abstract][Full Text] [Related]
26. Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.
Siddiqui JA; Pothuraju R; Khan P; Sharma G; Muniyan S; Seshacharyulu P; Jain M; Nasser MW; Batra SK
Cytokine Growth Factor Rev; 2022 Apr; 64():71-83. PubMed ID: 34836750
[TBL] [Abstract][Full Text] [Related]
27. A survey of the mouse hindbrain in the fed and fasted states using single-nucleus RNA sequencing.
Dowsett GKC; Lam BYH; Tadross JA; Cimino I; Rimmington D; Coll AP; Polex-Wolf J; Knudsen LB; Pyke C; Yeo GSH
Mol Metab; 2021 Nov; 53():101240. PubMed ID: 33962048
[TBL] [Abstract][Full Text] [Related]
28. Identification of GDF15 peptide fragments inhibiting GFRAL receptor signaling.
Alexopoulou F; Buch-Månson N; Pedersen SL; Vrang N; Fink LN; Strømgaard K
Peptides; 2023 Oct; 168():171063. PubMed ID: 37495041
[TBL] [Abstract][Full Text] [Related]
29. Dietary medium-chain fatty acids reduce food intake via the GDF15-GFRAL axis in mice.
Kanta JM; Deisen L; Johann K; Holm S; Lundsgaard A; Lund J; Jähnert M; Schürmann A; Clemmensen C; Kiens B; Fritzen AM; Kleinert M
Mol Metab; 2023 Aug; 74():101760. PubMed ID: 37356805
[TBL] [Abstract][Full Text] [Related]
30. Treatment with the TGF-b superfamily cytokine MIC-1/GDF15 reduces the adiposity and corrects the metabolic dysfunction of mice with diet-induced obesity.
Tsai VW; Zhang HP; Manandhar R; Lee-Ng KKM; Lebhar H; Marquis CP; Husaini Y; Sainsbury A; Brown DA; Breit SN
Int J Obes (Lond); 2018 Mar; 42(3):561-571. PubMed ID: 29026214
[TBL] [Abstract][Full Text] [Related]
31. Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior.
Igual Gil C; Coull BM; Jonas W; Lippert RN; Klaus S; Ost M
Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 36271504
[TBL] [Abstract][Full Text] [Related]
32. GFRAL-expressing neurons suppress food intake via aversive pathways.
Sabatini PV; Frikke-Schmidt H; Arthurs J; Gordian D; Patel A; Rupp AC; Adams JM; Wang J; Beck Jørgensen S; Olson DP; Palmiter RD; Myers MG; Seeley RJ
Proc Natl Acad Sci U S A; 2021 Feb; 118(8):. PubMed ID: 33593916
[TBL] [Abstract][Full Text] [Related]
33. Overview of growth differentiation factor 15 (GDF15) in metabolic diseases.
Li J; Hu X; Xie Z; Li J; Huang C; Huang Y
Biomed Pharmacother; 2024 May; 176():116809. PubMed ID: 38810400
[TBL] [Abstract][Full Text] [Related]
34. GDF15, an update of the physiological and pathological roles it plays: a review.
Assadi A; Zahabi A; Hart RA
Pflugers Arch; 2020 Nov; 472(11):1535-1546. PubMed ID: 32936319
[TBL] [Abstract][Full Text] [Related]
35. Targeting the divergent TGFβ superfamily cytokine MIC-1/GDF15 for therapy of anorexia/cachexia syndromes.
Tsai VW; Brown DA; Breit SN
Curr Opin Support Palliat Care; 2018 Dec; 12(4):404-409. PubMed ID: 30382947
[TBL] [Abstract][Full Text] [Related]
36. LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice.
Patel AR; Frikke-Schmidt H; Bezy O; Sabatini PV; Rittig N; Jessen N; Myers MG; Seeley RJ
Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G247-G255. PubMed ID: 34935522
[TBL] [Abstract][Full Text] [Related]
37. GDF15 is a major determinant of ketogenic diet-induced weight loss.
Lu JF; Zhu MQ; Xia B; Zhang NN; Liu XP; Liu H; Zhang RX; Xiao JY; Yang H; Zhang YQ; Li XM; Wu JW
Cell Metab; 2023 Dec; 35(12):2165-2182.e7. PubMed ID: 38056430
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of GDF15 as a therapeutic target of cardiometabolic diseases in human: A Mendelian randomization study.
Cheung CL; Tan KCB; Au PCM; Li GHY; Cheung BMY
EBioMedicine; 2019 Mar; 41():85-90. PubMed ID: 30772304
[TBL] [Abstract][Full Text] [Related]
39. GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with Cancer.
Ahmed DS; Isnard S; Lin J; Routy B; Routy JP
J Cancer; 2021; 12(4):1125-1132. PubMed ID: 33442410
[TBL] [Abstract][Full Text] [Related]
40. Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.
Borner T; Arnold M; Ruud J; Breit SN; Langhans W; Lutz TA; Blomqvist A; Riediger T
J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):417-427. PubMed ID: 28025863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
